FDA OKs Boston Scientific cardiac devices

02/25/2008 | FDAnews · Boston Globe (tiered subscription model), The

The FDA has granted Boston Scientific Corp. approvals for three of its cardiac devices: the Confient implantable cardioverter defibrillator, the Livian cardiac resynchronization therapy defibrillator and an upgraded Latitude patient management system. Doctors can wirelessly monitor their patients on the updated Latitude system with the aid of the other two devices.

View Full Article in:

FDAnews · Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Fort Worth, TX